NorthCoast Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

NorthCoast Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-28,088	Closed	-$1.41M	–	208
2016 Q2	$1.41M	Sell	28,088 -32,578	-54%	-$1.73M	0.1%	121
2016 Q1	$3.25M	Buy	+60,666	New	+$3.56M	0.28%	41
2015 Q4	–	Sell	-81,121	Closed	-$4.58M	–	188
2015 Q3	$4.58M	Buy	81,121 +954	+1%	+$61.9K	0.25%	51
2015 Q2	$4.74M	Buy	80,167 +12,200	+18%	+$753K	0.23%	57
2015 Q1	$4.23M	Sell	67,967 -1,835	-3%	-$107K	0.2%	56
2014 Q4	$4.01M	Buy	+69,802	New	+$3.89M	0.2%	61

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NorthCoast Asset Management's TEVA Position: Q3 2016 in Review

NorthCoast Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 28,088 shares — an estimated $1.41M sold.

NorthCoast Asset Management first reported a position in TEVA in Q4 2014 and held it in 6 quarters. The position peaked at $4.74M in Q2 2015. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

NorthCoast Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
NorthCoast Asset Management sold 28,088 Teva Pharmaceuticals shares in Q3 2016, an estimated $1.41M.
NorthCoast Asset Management first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 6 quarters.
NorthCoast Asset Management's Teva Pharmaceuticals position peaked at $4.74M in Q2 2015.
795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on NorthCoast Asset Management's 13F filing for Q3 2016, filed 9 Nov 2016.